AHA GUIDELINES Bundle (free trial)

Diagnosis and Management of Aortic Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1483260

Contents of this Issue

Navigation

Page 55 of 97

56 Treatment 6.5.5.3. Threshold for AAA Repair COR LOE Recommendations 1 A 1. In patients with unruptured AAA, repair is recommended in those with a maximal aneurysm diameter of ≥5.5 cm in men or ≥5.0 cm in women. 1 B-NR 2. In patients with unruptured AAA who have symptoms that are attributable to the aneurysm, repair is recommended to reduce the risk of rupture. 2b C-LD 3. In patients with unruptured saccular AAA, intervention to reduce the risk of rupture may be reasonable. 2b C-LD 4. In patients with unruptured AAA and aneurysm growth of ≥0.5 cm in 6 months, repair to reduce the risk of rupture may be reasonable. 6.5.5.4. Open Versus Endovascular Repair of AAA COR LOE Recommendations 1 A 1. In patients with nonruptured AAA with low to moderate operative risk and who have anatomy suitable for either open or EVAR, a shared decision-making process weighing the risks and benefits of each approach is recommended. 1 B-NR 2. In patients undergoing elective endovascular repair for nonruptured AAA, adherence to manufacturer's instructions for use is recommended. 2a B-NR 3. In patients with nonruptured AAA and a high perioperative risk, EVAR is reasonable to reduce the risk of 30-day morbidity, mortality, or both. 2a B-NR 4. For patients with nonruptured AAA, a moderate to high perioperative risk, and anatomy suitable for an FDA-approved fenestrated endovascular device, endovascular repair is reasonable over open repair to reduce the risk of perioperative complications.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Diagnosis and Management of Aortic Disease